Impact of Absolute Lymphocyte Count at Time of Antithymocyte Globulin on Outcomes of Allogeneic Unrelated Hematopoietic Cell Transplantation with Busulfan and Fludarabine Myeloablative Conditioning

被引：0
|
作者：
Chennamadhavuni, Adithya [1 ]
Nadiminti, Kalyan [2 ]
Dozeman, Lindsay [3 ]
Farooq, Umar [4 ]
Jethava, Yogesh [4 ]
Mott, Sarah [5 ]
Silverman, Margarida Magalhaes [3 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Mayo Clin, Hematol, Rochester, MN USA
[3] Univ Iowa Hosp & Clin, Div Hematol Oncol Blood & Marrow Transplantat, Iowa City, IA 52242 USA
[4] Univ Iowa, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA USA
[5] Holden Comprehens Canc Ctr, Iowa City, IA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128186
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5671
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes
    Chhabra, Saurabh
    Narra, Ravi K.
    Wu, Ruizhe
    Szabo, Aniko
    George, Gemlyn
    Michaelis, Laura C.
    D'Souza, Anita
    Dhakal, Binod
    Drobyski, William R.
    Fenske, Timothy S.
    Jerkins, James H.
    Pasquini, Marcelo C.
    Rizzo, R. Douglas
    Saber, Wael
    Shah, Nirav N.
    Shaw, Bronwen E.
    Hamadani, Mehdi
    Hari, Parameswaran N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (05) : 893 - 901
  • [32] Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning
    Lam, Wilson
    Storek, Jan
    Li, Haocheng
    Geddes, Michelle
    Daly, Andrew
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (03)
  • [33] Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
    Seo, Jeongmin
    Shin, Dong-Yeop
    Koh, Youngil
    Kim, Inho
    Yoon, Sung-Soo
    Byun, Ja Min
    Hong, Junshik
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [34] The Impact of the Absolute Lymphocyte Count before Anti-T-Lymphocyte Globulin (ATLG) Administration on Transplant Outcomes in Matched Unrelated Peripheral Blood Stem Cell Allogeneic Stem Cell Transplantation
    Massoud, Radwan
    Ursi, Margherita
    Barbato, Francesco
    De Felice, Francesco
    Maffini, Enrico
    Roberto, Marcello
    Klyuchnikov, Evgeny
    Langebrake, Claudia
    Gagelmann, Nico
    Zeck, Gabriele
    Niederwieser, Christian
    Lueck, Catherina
    Janson, Dietlinde
    Wolschke, Christine
    Ayuk, Francis A.
    Kroeger, Nicolaus
    Bonifazi, Francesca
    BLOOD, 2024, 144 : 7374 - 7375
  • [35] Impact of Adding Melphalan to Fludarabine and a Myeloablative Dose of Intravenous Busulfan for Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation
    Shimomura, Yoshimitsu
    Hara, Masahiko
    Yamamoto, Hisashi
    Ichinohe, Tatsuo
    Fukuda, Takahiro
    Takanashi, Minoko
    Atsuta, Yoshiko
    Ishikawa, Takayuki
    BLOOD, 2019, 134
  • [36] Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning
    DeCook, L. J.
    Thoma, M.
    Huneke, T.
    Johnson, N. D.
    Wiegand, R. A.
    Patnaik, M. M.
    Litzow, M. R.
    Hogan, W. J.
    Porrata, L. F.
    Holtan, S. G.
    BONE MARROW TRANSPLANTATION, 2013, 48 (05) : 708 - 714
  • [37] Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioning
    L J DeCook
    M Thoma
    T Huneke
    N D Johnson
    R A Wiegand
    M M Patnaik
    M R Litzow
    W J Hogan
    L F Porrata
    S G Holtan
    Bone Marrow Transplantation, 2013, 48 : 708 - 714
  • [38] Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
    Langenhorst, J. B.
    van Kesteren, C.
    van Maarseveen, E. M.
    Dorlo, T. P. C.
    Nierkens, S.
    Lindemans, C. A.
    de Witte, M. A.
    van Rhenen, A.
    Raijmakers, R.
    Bierings, M.
    Kuball, J.
    Huitema, A. D. R.
    Boelens, J. J.
    BLOOD ADVANCES, 2019, 3 (14) : 2179 - 2187
  • [39] MYELOABLATIVE DOSES OF BUSULFAN AND FLUDARABINE AS CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA
    Figueroa, J.
    Perkins, J.
    Anassetti, C.
    Tomblyn, M.
    Field, T.
    Fernandez, H.
    Ochoa, J.
    Perez, L.
    Alsina, M.
    Locke, F.
    Nishihori, T.
    Pidala, J.
    Ayala, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S297 - S297
  • [40] Treosulfan, fludarabine, and antithymocyte globulin - A low toxicity conditioning regimen for unrelated donor - Hematopoietic stem cell transplantation in chronic myeloid leukemia.
    Holowiecki, Jerzy
    Giebel, Sebastian
    Wojnar, Jerzy
    Markiewicz, Miroslaw
    Holowiecka-Goral, Aleksandra
    Wylezol, Wona
    Krawczyk-Kulis, Malgorzata
    Wozniczka, Krzysztof
    BLOOD, 2006, 108 (11) : 835A - 835A
12345